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Abstract
Diarrhoeal illness is a leading cause of child mortality and morbid-
ity worldwide. There are no precise or current estimates of the types
and prevalence of pathogens associated with diarrheal illnesses in
developed and developing settings. This systematic review assessed
data from 60 studies published in the English language from five
developing regions and developed countries worldwide to provide
regional estimates of enteric pathogens affecting children. The ran-
dom-effect method was used to establish the weighted average preva-
lence of pathogens in adults and children for each region.
Significantly more pathogens were reported by studies from develop-
ing regions compared with Organisation for Economic Co-operation
and Development countries (P<0.016). The identification rates of
pathogens from community based and hospital based studies were
similar (58.5% and 58.1% respectively, P<0.619). The overall detec-
tion of enteric pathogens in developing countries was higher in adults
(74.8%; 95% CI 63.1-83.8%) compared with children (56.7%; 95% CI
53.0-60.4%) (P<0.001). Rotavirus was the most frequently detected
pathogen in all regions with the highest rate, 24.8% (95% CI 18.0-
33.1%), detected in the developed countries. This systematic review is
the first to provide an estimate of the prevalence of enteric pathogens
associated with diarrhoeal illnesses in adults and children in devel-
oped and developing settings. While pathogen detection rate is
greater in developing regions the consistently high prevalence of
rotavirus in both developed and developing settings underscores the
urgent need for access to rotavirus vaccines. Increased travel between
developing and developed countries increases disease risk, and hence
developed countries have a vested interest in supporting vaccine
accessibility in developing settings. 
Introduction
Gastrointestinal (GIT) illnesses contribute significantly to the bur-
den of illness from infectious diseases worldwide. Diarrhoea is the
second leading cause of preventable illness in children under age
five.1-3 Despite the strong association between gastrointestinal illness-
es and factors such as poor sanitation, inadequate access to safe
drinking water and other risk factors, both resource-rich and less
developed countries alike are impacted by gastrointestinal illness.3,4
The risk factors however appear to be distributed differently between
developed and developing countries and as a result, the incidence of
specific pathogens may differ between each setting.5 Several studies
have described the pathogens, associated risk factors and the costs
and burden of illness on health care. However, there are few studies
that estimate the prevalence of pathogens affecting populations in dif-
ferent regions worldwide. Developing countries world often experi-
ence similar sanitation and poverty related risk factors, which predis-
poses their population to diarrhoeal illnesses. However, the incidence
of illness in developed countries tend to be less generic and more relat-
ed to seasonality, travel and food borne transmission.4
Several enteric micro-organisms are responsible for GIT illnesses
and are bacterial, viral or parasitic in nature.6 A review of the litera-
ture world-wide indicates that a causative organism is identified in
about 50% of symptomatic cases.7-10 In resource-limited settings
under-reporting is possible, with the data biased towards certain
pathogens and relate mainly to specific age groups.1,11,12 
There are few estimates of the prevalence and distribution of
pathogens that cause GIT illnesses, which indicate there may be sig-
nificant differences in the prevalence of certain pathogens in circula-
tion in developing and developed settings.13-15 Determining the preva-
lence of pathogens on a regional basis will assist in the development
of appropriately targeted prevention and control strategies, identify
gaps in surveillance and provide support for the strengthening of lab-
oratory diagnostic capacity at the regional level. It can also assist in
the management of the health needs of travelers to different regions. 
This paper provides an overview of gastrointestinal illnesses and a
systematic review of the literature to provide region-specific GIT
pathogen detection rates associated with cases in developed countries
and developing regions. Firstly, an overview of gastrointestinal illness-
es including definitions, and disease transmission and risk factors are
presented. Then an estimate of the detection of enteric pathogens is
provided based on studies worldwide.Definition of gastrointestinal illness
The term gastrointestinal illness refers to several conditions affect-
ing the gastrointestinal system that exhibits watery or unformed stools
and are usually caused by infections or intoxications with a biological
Significance for public health
This research is significant in that it provides an evidence base for the
advancement in understanding global disease burden and the development
of public health and research priorities. Understanding that people in both
developed and developing settings are affected by similar pathogens to dif-
ferent degrees and requires cross border sharing and learning for their con-
trol. The prevalence of rotavirus underscores the need for improved access
to rotavirus vaccines in both settings. Rotavirus vaccines have efficaciously
reduced gastroenteritis burden where they have been introduced and hence
likely to do so in developing settings. The global public health community
should support efforts to make rotavirus vaccines available at affordable
costs to the poorest people of the world, where disease burden and mortality
is highest. Developed countries should support developing regions to imple-
mentation effective programs for the prevention and control of gastrointesti-
nal infections, since infectious pathogens know no boundaries.
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agent.16 Because of the various causes, variable symptomology, and
numerous different terms used to describe disease of the gastrointesti-
nal tract, no standard definition of gastrointestinal diseases has been
presented in the medical literature.17 For the purposes of this study,
gastrointestinal illness refers to any illness of the gastrointestinal tract
caused by a microbe causing chronic or acute diarrhea, whether or not
accompanied by nausea, or vomiting, combined with abdominal pain,
or systemic symptoms such as fever. A suspected case is any case hav-
ing met the criteria for a clinical diagnosis (see below). A confirmed
case is any suspect case that has a laboratory confirmation of an
enteric disease pathogen isolated from a clinical specimen. 
Diarrhoeal illness is usually divided into three main categories
based on its clinical presentation:18
- Acute watery diarrhoea associated with several pathogens such as
Vibrio cholera and rotavirus, usually last for several days, and poses
a high risk for dehydration which can be fatal especially in young
children, the elderly and immuo-compromised persons.18
- Acute bloody diarrhoea or dysentery is usually evidence of infection
with Campylobacter, Salmonella, Shigella, enterohaemorrhagic E.
coli pathotypes, Entamoeba histolytica and other organisms, and can
lead to dehydration. The major risks associated with this presenta-
tion include intestinal damage, sepsis and malnutrition.18
- Persistent diarrhoea lasts for 14 or more days and is usually associat-
ed with parasitic aetiology but can be due to non-infectious causes
such as inflammatory bowel disease. Due to the prolonged duration
of persistent diarrhoea there is a risk of nutrient deficiency, extra
intestinal infection and dehydration especially in children, the elder-
ly and immuno-compromised.18
Overview of gastrointestinal illness
Gastrointestinal illnesses can be either acute self-limiting infections
or chronic idiopathies.19 Both acute and chronic infections can be
caused by pathogenic bacteria, viruses and parasites. Diarrhoea can
also be caused by idiopathic diseases arising from internal dysfunc-
tions of gastrointestinal tract include diseases such as Idiopathic bowel
disease, Crohn’s disease and ulcerative colitis.19,20 The majority of gas-
trointestinal illnesses are self-limited,19 however, certain risk factors
such as malnutrition, immunosuppression, and young age predisposes
the development of persistent diarrhea.18 Patients with immune defi-
ciencies (congenital, iatrogenic or acquired) are unusually more sus-
ceptible to infections and are at an increased risk for malignancy.21Disease transmission and risk factors
Infectious gastrointestinal illnesses are transmitted through a vari-
ety of routes including contaminated food or water borne, the faecal
oral route, and person-to-person.16,22 A significant proportion, about
36%, of gastrointestinal illnesses is attributable to food borne transmis-
sion.23,24 Among all illnesses attributable to food borne transmission,
30% are caused by bacteria, 3% by parasites, and 67% by viruses.23 In
the USA for example, nontyphoidal Salmonella spp. (35%), norovirus
(26%), Campylobacter spp. (15%), and Toxoplasma gondii (8%) were
the leading causes of hospitalization in 2000-2008.23,25 Salmonella,
Listeria, Toxoplasma, and norovirus are responsible for more than 75%
of deaths related to known causes of food borne illness each year.6,23,25
In Australia about 32% of all gastroenteritis are foodborne, and
Campylobacter, non-typhoid Salmonella, pathogenic E. coli and
norovirus are responsible for over 80% of foodborne illness from known
pathogens.26,27 In Australia the highest rates of gastroenteritis in the
general population has been reported among young children and their
adult carers.28
The majority of gastrointestinal illnesses can be transmitted through
the faecal-oral route. Infections with pathogenic E. coli strains are usu-
ally considered an indication of poor hygiene. Up to 63% of children
with persistent diarrhoea in low and middle income countries have
tested positive for E. coli strains.10 Travel-associated diarrhoea has
been described and travel to a developing region is a risk factor among
patients presenting with diarrhoea in developed settings.29,30 Studies
have reported that travellers to low and middle income countries are
between 9 and 151 times more likely to develop diarrhoeal illness,14,31
with the highest risk associated with travel to areas in South America,
Africa and South Asia.14,32,33
Methodology for estimating pathogen detec-tion ratesSearch strategy 
Studies reporting the aetiology of diarrhoeal illness were identified
from a search of databases including Science Direct, PubMed, PubMed
Central, and Google scholar for articles published from 1980 and 2010.
The search was not restricted to publications in the English Language,
only to studies that had abstracts in English. The key subject terms
included one or combinations of the following: infectious intestinal
pathogen AND humans, diarrhea (or diarrhoea) and pathogen, aetiolo-
gy (etiology) of acute gastroenteritis OR diarrhoea, enteric infectious
pathogens. Boolean operators (not, and, or) were also used in succes-
sion to narrow and widen the searches. Other articles were identified
by using the PubMed option of related articles and checked the refer-
ence lists of the original and review articles. Eligibility and study selection criteria
Eligibility of studies for inclusion includes the following criteria: 
- Detailed results of microbiological analysis of stool samples and the
number of samples tested; 
- Subjects defined as clinically symptomatic or asymptomatic;
- Number of study subjects and positive results for both cases/controls; 
- Definition of symptomatic subjects (case) as persons who had diar-
rhoea (defined as three or more loose/watery stools in a 24 hour
period), or loose stools associated with gastrointestinal symptoms
including: vomiting, abdominal pain or cramps, and blood or mucus
in stool.34
Detection rates for adults and children were provided as age-specific.Excluded studies
Studies were excluded where data were provided without adequate
information for the detection and age-specific rates to be calculated,
where the focus was on a single pathogen, or data were presented as
the number of diarrhoeal episodes rather than samples tested. Data abstraction and analysis
Selected studies were summarised in tabular format to include data
on study design, study population, source of sample and sample size,
methods to detect enteric pathogens, and detection rates. Where stud-
ies included combined age-groups that provided adequate data for chil-
dren and adults separately, the data for children and adults were record-
ed separately. Countries were categorised into developing regions cat-
egories, based on the World Bank List of Economies published in July
2009,35 including: East Asia Pacific (EAP), Latin America and
Caribbean (LAC), Middle East and Northern Africa (MENA), Sub-
Saharan Africa (SSA), and South Asia and the Pacific (SAP). Developed
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countries were categorised based on the Organisation for Economic
Co-operation and Development (OECD) category of countries.35,36 Two
non-OECD developed countries [Republic of (South) Korea and
Turkey] were also included in this category (Supplementary Table S1). 
Analysis and synthesis of results
Estimates of the prevalence of diarrhoeal pathogens were calculated
by region. As studies were conducted in different regions using differ-
ent methods and approaches the pooled prevalence of pathogens was
estimated using the DerSimonian-Laird random-effect (RE) method.37
The pooled or weighted RE estimate of pathogen prevalence was calcu-
lated using the Comprehensive Meta-analysis (CMA) programme.38
The estimated mean prevalence was reported with 95% Confidence
Intervals (95% CI). 
Estimating the prevalence of gastrointestinalpathogens Description of studies
The search produced 10,288 papers and the abstracts of 121 were
included in our critical review. Data from 60 studies (from 47 develop-
ing and 13 developed countries) met the inclusion criteria for analy-
sis.7,8,39-97 The studies included are summarised in Table 1. Of the stud-
ies reviewed, one presented multi-country data (two in EAP, one in LAC,
two in SAP) which was tabulated and analysed under individual coun-
try/region.40 Three studies had sufficient data to allow the tabulation
and analysis of findings for children and adults separately.62,94,95 These
brought the total number of studies reviewed to 67. Most studies (73%,
44/60) recruited subjects from hospital settings and the remainder
(17%, 16/60) were recruited from community or mixed settings.
Studies were classified into six groups: five developing regions and
OECD (developed) countries. 
The summary of the laboratory procedures employed in each study is
presented in Table S1. For the detection of bacteria, standard culture
methods often coupled with serological tests, DNA hybridization,
enzyme immunoassays (EIA) and polymerase chain reaction (PCR)
were employed for the detection of different pathotypes of pathogenic
E. coli. In some cases antibiotic susceptibility testing was performed by
the disk diffusion or plate dilution methods. The majority of viral stud-
ies focused on rotavirus, employing mainly enzyme linked immunosor-
bent assay (ELISA), EIA, and less frequently, latex slide agglutination
test and PCRs. Microscopic examination of permanently stained films
have been generally used for the detection of ova cyst and parasites
along with a modified Ziehl-Neelsen stain for coccidian parasites. Overall detection of pathogens
Source of cases
There was no significant difference in the detection of total number
of pathogens in community or hospital settings (P>0.05). In 13 com-
munity based studies from four regions, enteric pathogens were detect-
ed in an average of 57.8% (95% CI, 49.2-65.9%) of cases, ranging from
52.4% in the EAP region to 62.6% in the SSA region. There was a sig-
nificant difference in detection rates from 44 hospital based studies
across the six regions, (P=0.001). The average detection of enteric
pathogens was 58.1% (95% CI, 54.0-62.0%) of hospitalised cases, with
a range of 36.9% (95% CI, 31.7-56.2%) in the MENA region to 66.7%
(95% CI, 58.9-72.4%) in the SAP region (Table 2). 
Age groups
In children, a pathogen was detected on average 56.7% (95% CI, 53.0-
60.4%) with the lowest detection rate of 43.6% (95% CI, 31.7-56.2%) in
the MENA region and the highest detection rate of 64.4% (95% CI, 57.6-
70.7%) in the SAP region. Conversely, the detection rate of pathogens
in adults on average was 74.8% (95% CI, 63.1-83.8%). The highest rate
was among adults from the MENA region (90.4%; 95% CI, 81.2-95.4%)
and the lowest rates of detection was among adults from OECD coun-
tries (32.5%; 95% CI, 14.7-57.3%) (Table 2). Regional distribution of enteric pathogens
Children
The weighted average detection rate for enteric organisms in chil-
dren for each region identified rotavirus as the most frequently detect-
ed pathogen in children (Table 3). The rates ranged from a low of 4.8%
(95% CI, 2.6-8.7%) in SSA region to as high as 24.8% (95% CI, 18.0-
33.1%) in OECD countries. The detection of rotavirus from diarrhoeal
cases was up to five times more in OECD countries than in developing
regions. Adenovirus 4.5% (95% CI  3.3-6.1%) and norovirus 3.3% (95%
CI, 1.9-5.7%) were also most frequently detected in OECD countries
when compared with developing regions. On average, E. coli patho-
types [Enterotoxigenic E. coli (ETEC), Enteropathogenic E. coli
(EPEC)] and other pathogenic E. coli spp. were prevalent across all
developing regions. The highest rates of EPEC were detected in the
SAP region (8.5%; 95% CI, 5.4-13.1%) followed by the LAC region (5.6%;
95% CI, 2.3-12.6%); while ETEC was most prevalent in the SAP region
and other E. coli pathotypes were also common in the MENA region
(10.6%; 95% CI, 4.2-24.3%). Campylobacter spp., was also frequently
detected in developing regions with the highest rate of detection in the
SAP (6.6%; 95% CI, 3.9-10.9) and LAC (5.5%; 95% CI, 2.8-10.4) regions.
Salmonella spp and Shigella spp were frequently detected among chil-
dren in developing regions with Salmonella (4.1%; 95% CI, 2.8-5.9%)
and Campylobacter spp (3.4%; 95% CI, 2.3-4.9%) the most frequently
detected bacterial pathogens in children in developed countries.
Parasites were less frequently detected; yet Giardia intestinalis was
the most frequently detected protozoa in developing regions, with the
highest prevalence found in SAP (3.0%; 95% CI, 1.5-5.9%) and SSA
(2.7%; 95% CI, 1.8-4.3%) regions. Entamoeba spp were frequently
detected in MENA (1.5%; 95% CI, 0.6-4.2%) and SSA (1.5%; 95% CI, 0.9-
2.5%) regions while Cryptosporidium was more prevalent in in the
MENA (1.0%; 95% CI, 0.2-4.9%) and SAP (1.7; 95% CI, 0.8-3.1%)
regions. Another protozoa, Dientamoeba fragilis, was found in <1% of
cases in each region.
Adult patients were assessed for only three regions: MENA, SSA and
the OECD countries (Table 4). Amongst adult patients Cryptosporidium
sp. (9.4%; 95% CI, 1.0-50.2%), Salmonella spp (4.0%; 95% CI, 0.2-
43.5%), other pathogenic E. coli (3.6%; 95% CI 0.3-36.2%), and Shigella
sp. (2.2%; 95% CI, 1.1-4.5%) were quite common in the SSA region.
Frequent viral pathogens detected in stools of adults from OECD coun-
tries were norovirus (10.5%; 95% CI, 7.5-14.7%), rotavirus (3.6%; 95%
CI, 1.4-9.2%) and Campylobacter (3.3%; 95% CI, 0.9-12.0%).  
Discussion 
The paucity of information concerning the prevalence of diarrhoeal
pathogens in different world regions has resulted in the conduct of this
systematic review. This is the first study that has attempted to provide
an estimate of the prevalence of enteric pathogens in both developed
and developing settings. Several fundamental conclusions can be
drawn from these findings. This review found i) developing regions
have significantly more pathogens isolated than the OECD countries,
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Table 1. Summary of 60 studies included in the systematic review of gastrointestinal pathogens worldwide.
Study details Laboratory analysis (tests done)
Region Country First author/ Study Study Source Sampling Age Sample Bacterial 
(studies) year (ref) period design of specimen method groups size culture
(yrs)
EAP (13) Burma Tin 1989 (39) 1982-1983 Case control Community Consecutive 0-5 501 cases, Bacteriology, 
374 controls virology
China Huilan Sima 1991 (40) 1982-1985 Case control Hospital Consecutive 0-3 594 cases, Bacteriology, 
562 controls virology, parasitology
China Kain Kevin 1991 (41) 1989-1989 Case control Hospital Consecutive 0-5 221 cases, Bacteriology, 
108 controls virology, parasitology
Indonesia Soenarto 1983 (43) 1978-1979 Case control Hospital Consecutive 0-12 338 cases, Bacteriology, 
69 controls virology, parasitology
Myanmar Huilan 1991 (40) 1982-1985 Case control Hospital Consecutive 0-3 813 cases, Bacteriology, 
813 controls virology; parasitology
Vietnam Hien. 2007 (50) 2002-2004 Case control Community Consecutive 0-6 111 cases, Bacteriology, 
111 controls virology; parasitology
Vietnam Isenbarger 2001 (47) 1998-1999 Case control Hospital/PHC Consecutive 0-5 2160 cases, Bacteriology,
203 controls
Vietnam Nguyen 2006 (49) 2000-2002 Case control Hospital/ Consecutive 0-5 587 cases, Bacteriology, 
community 249 controls virology
China Yu 2008 (42) 2006-2007 Cross-sectional Hospital Consecutive 0-5 1216 cases Virology 
Laos PDR Yamashiro 1998 (44) 1996-1997 Cross-sectional Hospital/PHC Consecutive 0-15 880 cases Bacteriology, virology 
Taiwan Liu 2005 (45) 2000-2001 Cross-sectional Hospital Consecutive 0-3 657 cases Bacteriology, virology 
Taiwan Lu 2006 (46) 2001-2002 Cross-sectional Hospital Systematic random 0-5 768 cases Bacteriology, virology 
Thailand Bodhidatta 2002 (48) 1998-2000 Cross-sectional Hospital Consecutive 0-12 623 cases Bacteriology 
LAC (80) Brazil Seigel 1996 (51) 1994-1994 Case control Hospital Consecutive 0-5 112 cases, Bacteriology, virology
106 controls
Mexico Huilan 1991 (40) 1982-1985 Case control Hospital Consecutive 0-3 559 cases, Bacteriology, virology;
559 controls parasitology
Mexico Paniagua 2007 (55) 2004-2006 Case control Hospital Consecutive >2 -<12 300 cases, Bacteriology, 
80 controls parasitology
Peru Pazzaglia 1991 (56) 1988-1989 Case control Hospital Consecutive 0-2 391 cases, Bacteriology, virology; 
138 controls
Peru Ochoa 2009 (54) 2006-2007 Case control Community Consecutive 0-1 936 cases, Bacteriology, virology; 
424 controls
Brazil Barreto 2006 (52) 2000-2002 Cross-sectional Community Random 0-3 1233 cases Bacteriology, virology;
parasitology
Mexico Flores-Abuxapqui 1994 (53) 1991-1991 Cross-sectional Community Consecutive 0-2 148 cases Bacteriology, virology; 
parasitology 
Uruguay Torres 2001 (57) 1990-1994 Cross-sectional Hospital Consecutive 0-4 224 cases Bacteriology, virology;
parasitology
MENA (8) Tunisia Al-Gallas 2007(62) 2001-2004 Case control Hospital/PHC Consecutive 0-15 115 cases, Bacteriology, virology;
(divided into 18-80 73 controls; parasitology
2 age gps) 54 cases, 
29 controls
Egypt El-Mohamady 2006 (58) 2003-2003 Cross-sectional Hospital Consecutive 0-5 356 cases Bacteriology, virology;
parasitology
Gaza Elamreen 2007 (59) 2005-2005 Cross-sectional Hospital Consecutive 0-5 150 cases Bacteriology 
Jordan Youssef 2000 (61) 1993-1994 Cross-sectional Hospital Consecutive 0-5 265 cases Bacteriology, virology;
parasitology 
Saudi Arabia El-Sheikh 2001 (60) 1995-1996 Cross-sectional Hospital/PHC Consecutive 0-5 576 cases Bacteriology, virology;
parasitology
nOECD (2) Rep. of Korea Kyung-Hee 1989 (73) 1984-1985 Case control Hospital Consecutive 0-15 231 cases, Bacteriology, virology; 
(South) 104 controls (no in controls)
Turkey Uysal 1997 (75) 1993-1994 Cross-sectional Hospital Consecutive 0-14 400 Bacteriology, virology;
Parasitology
OECD (11) Denmark Olesen 2005 (65) 2000-2001 Case control Hospital Consecutive 0-5 424 cases, Bacteriology, virology;
866 controls parasitology 
Australia Barnes 1998 (63) 1980-1993 Cross-sectional Hospital Consecutive 0-14 3785 cases, Bacteriology, virology;
parasitology
Australia McIver 2001 (64) 1997-1998 Cross-sectional Hospital Random 0-5 412 cases, Bacteriology, virology;
parasitology 
England O'Neill 2002 (95) 2000-2001 Cross-sectional Hospital Consecutive 10-90 735 cases Virology; parasitology
0-5 1051 cases
To be continued on the next page.
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Table 1. Continued from previous page.
Study details Laboratory analysis (tests done)
Region Country First author/ Study Study Source Sampling Age Sample Bacterial 
(studies) year (ref) period design of specimen method groups size culture
(yrs)
Russia Podkolzin 2009 (94) 2005-2007 Prospective Hospital Consecutive 14-60 1354 cases Virology
0-5 2848 cases
Finland Rautelin 1989 (66) 1985-1986 Cross-sectional Hospital Consecutive 15-60 253 cases, Bacteriology, virology;
parasitology
Germany Jansen 2008 (96) 2005-2007 Cross-sectional Hospital Consecutive 18-60 132 cases, Bacteriology, virology;
parasitology
Greece Levidiotou 2009 (67) 2000-2006 Cross-sectional Hospital Consecutive 0-5 4604 cases, Virology
Italy Colomba 2006 (68) 1999-2000 Cross-sectional Hospital Consecutive 0-12 215 cases, Bacteriology, virology;
parasitology 
New Zealand Montgomery 2006 (74) 2005-2005 Cross-sectional Hospital Consecutive 0-15 128 Bacteriology, virology;
parasitology 
USA Klein 2006 (72) 1998-2001 Cross-sectional Hospital Consecutive 0-5 372 cases, Bacteriology, virology;
parasitology 
SAP (7) Bangladesh Albert 1999 (69) 1993-1994 Case control Hospital Systematic 0-5 814 cases, Bacteriology, virology;
random 814 controls parasitology
India Huilan 1991 (40) 1982-1985 Case control Hospital Consecutive 0-3 916 cases, Bacteriology, virology; 
587 controls parasitology
India Ghosh 1991 (70) 1986-1988 Case control Hospital Consecutive 0-1 218 cases, Bacteriology, virology; 
102 controls parasitology
Nepal Hoge 1995 (78) 1994-1994 Case control PHC Consecutive 0-5 124 cases, Bacteriology, virology;
103 controls parasitology
Pakistan Huilan 1991 (40) 1982-1985 Case control Hospital Consecutive 0-3 758 cases, Bacteriology, virology;
758 controls parasitology
Bangladesh Haque 2003 (71) 1999-2002 Cross-sectional Community Consecutive 0-5 289 cases, Bacteriology, virology;
parasitology
India Dutta 1991 (8) 1990 Cross-sectional Hospital Consecutive 0-5 383 cases, Bacteriology, virology;
parasitology
SSA (18) Central Georges 1984 (7) 1981-1982 Case control Hospital Consecutive 0-15 1197 cases, Bacteriology, virology;
African Rep 748 controls parasitology
Central Germani 1998 (77) 1995-1996 Case control Hospital Consecutive 18-80 290 cases, Bacteriology, virology; 
African Rep 140 controls parasitology
Ghana Reither 2007 (79) 2005-2006 Case control PHC Consecutive 0-12 243 cases, Bacteriology, virology;
124 controls parasitology
Nigeria Ogunsanya 1994 (83) 1989-1990 Case control Hospital Consecutive 0-5 215 cases, Bacteriology, virology;
100 controls parasitology
Zaire
De Mol 1983 (90) 1979-1979 Case control Hospital Consecutive 0-5 355 cases, Bacteriology, virology; 
320 controls parasitology
Zaire Henry 1995 (91) 1990-1990 Case control Hospital/PHC Cluster random 0-5 173 cases, Bacteriology, virology;
155 controls parasitology
Burkina Faso Djeneba 2007 (76) 2006 Cross-sectional GP Consecutive 0-5 66 cases, Virology; parasitology
Cameroon Yongsi 2008 (80) 2000-2005 Cross-sectional Community Stratified random 0-5 437 cases, Bacteriology, virology;
parasitology 
Nigeria Olowe 2003 (84) 2001-2002 Cross-sectional Hospital Consecutive 0-5 135 cases, Bacteriology,
Nigeria Cajetan 2010 (87) 2008-2008 Cross-sectional Hospital Random 0-5 404 cases, Bacteriology, 
Tanzania Vargas 2004 (89) 1996-1997 Cross-sectional Hospital Consecutive 0-5 451 cases, Bacteriology, virology;
parasitology
Uganda Musiime 2009 (88) 2008-2008 Cross-sectional Hospital Consecutive 0-5 190 cases, Bacteriology, 
Zambia Kelly 1996 (92) 1994 Cross-sectional Hospital/ Consecutive 18-80 77 cases, Parasitology
community 
Nigeria Ogbu O 2008 (82) 2005-2006 Case control PHC Consecutive 0-3 150 cases, Bacteriology, virology; 
50 controls parasitology 
Uganda Brink 2002 (86) 1995-1997 Case control PHC Consecutive 0-15 357 cases, Bacteriology, 
127 controls parasitology
Zambia Nakano 1998 (93) 1992-1993 Cross-sectional PHC Consecutive 0-5 639 cases, Bacteriology 
Nigeria Anynwu 1997 (81) 1997-1997 Case control Hospital Consecutive 0-5 1015 cases,  Bacteriology 
401 controls
Kenya van Eijk 2009 (85) 1997-2001 Prosp. cohort Hospital Consecutive 0-2 630 cases Bacteriology, virology;
parasitology 
Specimens were obtained from persons seen at hospitals, Primary Health Care Centre (PHC), General Practitioner (GP), or from the community. Sampling methods include taking consecutive (or convenience or census) specimen, systematic random,
random, stratified random sampling and some studies collected samples from routine surveillance programmes. Cas cont. = case control study; cross-sect. = cross sectional; Cohort = prospective follow-up studies. MENA = Middle East and North
Africa; EAP= East Asia & the Pacific; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD. Source: World Bank Country Classification July 2009. Available at http://go.world-
bank.org/D7SN0B8YU0. Accessed December 29, 2009.
No
n-c
om
me
rci
al 
us
e o
nly
ii) the identification of pathogens from community based studies was
similar to those in hospital based studies, iii) the overall detection of
enteric pathogens is higher amongst adults than in children in devel-
oping settings, iv) enteric viruses (rotavirus, adenovirus and
norovirus) were more frequently detected in paediatric cases in devel-
oped countries than in developing countries, and v) bacterial
pathogens are frequently detected amongst children and adults in
developing regions. 
This review found that developing regions had significantly more
pathogens isolated than the OECD countries. A WHO report indicated
that in 2008 the SSA and SAP regions accounted for more than three
quarters of the deaths in children from diarrhoeal disease.11 Several
travel based studies suggest that travel to South America, Africa, and
South Asia poses the greatest risk for travelers’ diarrhoea.14,32,33 South
Asia continues to be affected by a disproportionately higher incidence
of diarrhoeal illness in countries such as India and Bangladesh.
Support to developing regions for the development of targeted interven-
tions such as food safety programs that can successfully reduce the
rates of travelers’ diarrhoea amongst tourists,98-100 and provide evi-
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Table 2. Age specific and source related regional estimate of overall pathogen detection.
Overall Children Adults All cases Hospital Community
detection rate
Regions Number Detection Number of Detection Number of Detection Detection rate % Detection rate % 
of studies rate  (95% CI) studies rate % (95% CI) studies rate % (95% CI) (95% CI) (95% CI)
SAP 7 64.4 (57.6-70.7) 0 N/R 13 54.1 (43.9-63.9) 66.7 (58.3-74.1) 58.7 (55.6-61.7)
LAC 8 61.0 (51.2-70.1) 0 N/R 8 61.0 (51.2-70.1) 65.0 (56.3-72.8) 52.6 (35.6-69.1)
SSA 16 59.4 (48.5-69.3) 2 69.7 (39.6-89.0) 6 54.5 (40.2-68.1) 52.8 (39.9-65.4) 62.6 (43.3-78.6)
EAP 13 54.1 (43.9-63.9) 0 N/R 7 64.4 (57.6-70.7) 59.4 (49.7-68.5) 52.5 (27.7-76.1)
MENA 5 43.6 (31.7-56.2) 1 90.4 (81.2-95.4) 18 60.5 (50.6-69.7) 36.9 (22.0-54.9) N/R
OECD 11 50.1 (42.5-57.7) 4 32.5 (14.7-57.3) 15 45.2 (37.2-53.5) 50.4 (42.5-58.3) N/R
Total 60 56.7 (53.0-60.4) 7 74.8 (63.1-83.8) 67 57.2 (53.4-60.9) 58.1 (54.0-62.0) 58.5 (55.6-61.4)
Random-Effect estimate [Q (df) P-value] for difference between hospital and community based studies = 0.25 (1) 0.619; Adults =  (20.7 (2) 0.001 and children = 13.2 (5) 0.022; regions = 13.9 (5) 0.016. The weighted
mean detection rate is calculated by dividing number of positive stool tests for individual pathogens by the total number of specimen tested. DerSimonian-Laird random-effect (RE) method was calculated on the basis
of the Cochran’s Q-test with alpha set at the 5% level. Regions: EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa;
OECD= Developed Countries including non-OECD developed countries. N/R= not reported.
Table 3. Weighted average prevalence of enteric pathogens from children 0-12 years in developing regions and OECD countries.
EAP LAC MENA OECD SAP SSA
N. of studies (60) 13 8 5 11 7 16
Pathogens Detection rate % Detection rate % Detection rate % Detection rate % Detection rate % Detection rate %
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Bacteria
Aeromonas 0.1 (0.0-0.6) 0.3 (0.00-6.9) 0.7 (0.3-1.9) 0.1 (0.04-0.2) 2.9 (1.4-6.1) 0.3 (0.2-0.6)
Campylobacter jejuni 2.1 (1.0-4.2) 5.5 (2.8-10.4) 2.4 (1.1-5.5) 3.4 (2.3-4.9) 6.6 (3.9-10.9) 2.7 (1.5-4.8)
EPEC 2.9 (1.7-4.8) 5.6 (2.3-12.6) 1.4 (0.3-6.6) 0.2 (0.1-0.9) 8.5 (5.4-13.1) 3.2 (2.0-5.2)
ETEC 4.1 (2.2-7.5) 5.9 (3.1-11.2) 5.4 (1.7-15.6) 0.1 (0.01-1.6) 12.7 (8.6-18.3) 1.0 (0.5-2.1)
Other diarrh E. coli pathotypes 1.7 (0.8-3.4) 1.9 (0.5-6.8) 10.6 (4.2-24.3) 0.4 (0.1-1.2) 1.8 (0.5-5.6) 4.3 (2.1-8.6)
Salmonella spp. 2.8 (1.5-5.4) 1.7 (0.3-9.2) 3.2 (1.6-6.5) 4.1 (2.8-5.9) 2.5 (1.6-3.8) 3.6 (2.5-5.0)
Shigella spp. 4.4 (2.8-7.0) 2.9 (1.4-6.1) 3.5 (2.4-5.3) 0.5 (0.1-2.1) 5.6 (3.0-10.1) 4.3 (2.6-7.0)
Vibrio cholerae 0.2 (0.1-0.4) 0.2 (0.1-0.5) 0.2 (0.1-0.7) 0.1 (0.04-0.3) 2.1 (1.0-4.8) 0.4 (0.1-0.9)
Viruses
Astrovirus 0.1 (0.0-0.6) 0.4 (0.2-0.8) 0.2 (0.1-0.7) 1.3 (0.7-2.7) 0.1 (0.04-0.3) 0.2 (0.1-0.7)
Adenovirus type 40/41 0.4 (0.2-0.9) 0.5 (0.2-1.6) 0.2 (0.1-0.7) 4.5 (3.3-6.1) 1.5 (0.6-3.4) 0.5 (0.2-1.5)
Norovirus 0.2 (0.1-0.7) 0.3 (0.1-1.6) 0.2 (0.1-0.7) 3.3 (1.9-5.7) 0.7 (0.3-1.8) 0.2 (0.1-0.9)
Rotavirus 12.1 (7.4-19.3) 12.0 (7.4-19.0) 14.4 (7.8-25.0) 24.8 (18.0-33.1) 7.9 (4.7-12.8) 4.8 (2.6-8.7)
Parasites
Ascaris 0.2 (0.0-0.7) 0.3 (0.1-1.0) 0.5 (0.2-1.1) 0.1 (0.04-0.2) 0.1 (0.04-0.3) 0.3 (0.1-1.1)
Blastocystis spp. 0.1 (0.0-0.2) 0.1 (0.1-0.4) 0.2 (0.1-0.7) 0.1 (0.04-0.5) 0.1 (0.04-0.3) 0.2 (0.1-0.3)
Cryptosporidium sp 0.1 (0.1-0.2) 0.2 (0.1-2.0) 1.0 (0.2-4.9) 0.3 (0.1-0.5) 1.7 (0.8-3.1) 0.3 (0.1-0.9)
Dientamoeba fragilis 0.1 (0.1-0.2) 0.1 (0.1-0.4) 0.2 (0.1-0.7) 0.1 (0.03-0.2) 0.1 (0.1-0.3) 0.2 (0.1-0.3)
Entamoeba spp. 0.1 (0.1-0.9) 0.6 (0.1-6.5) 1.5 (0.6-4.2) 0.1 (0.03-0.4) 0.6 (0.1-2.5) 1.5 (0.9-2.5)
Giardia intestinalis 0.1 (0.1-0.3) 1.9 (0.6-6.5) 1.2 (0.5-3.2) 0.3 (0.1-0.8) 3.0 (1.5-5.9) 2.7 (1.8-4.3)
EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD developed
countries. EPEC- Enteropathogenic E. coli; ETEC- Enterotoxigenic E. coli.  
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dence for vaccine development should be a priority for developed coun-
tries.101 While the source of difference in pathogen prevalence between
both settings cannot be determined from the information provided in
the studies, we suggest that it is likely to be related, in part, to factors
such as socioeconomic status, access to potable water and sanitation
solutions. These factors were not explicitly described in many studies
but are known important predictors of diarrhoea incidence in develop-
ing settings.102
The identification of pathogens from community based studies was
similar to those in hospital based studies; however regional differences
may exist between the settings. Even though there were no significant
differences in the overall detection of pathogens between community
and hospital based studies, differences were observed within hospital
based studies between regions. One explanation for this may be hospi-
tal setting cases have severe clinical symptoms and were more likely to
be tested compared with cases from the community setting.
The overall detection of enteric pathogens was higher amongst
adults than in children in developing settings. The contrary is true for
developed settings. Whilst this may be due to underlying sample sizes
and testing methodologies employed, there is some evidence to suggest
that several new and emerging pathogens are not routinely detected in
clinical laboratories. Considering the majority of the studies involving
children were from developing regions, limited laboratory capacity may
have precluded the identification of organisms that require very sensi-
tive diagnostic techniques, such as viral pathogens and some enteric
protozoa.103-106 There is a need for the development of inexpensive sen-
sitive and specific diagnostic methods to improve pathogen detection
in clinical laboratories.15,107-110 Some exposures increase the risk for
infections in older children and adults, that could influence the types of
pathogens that infect them including poor hygiene practices, foodborne
infections and different environmental risk factors.111
Enteric viruses were more frequently detected in paediatric cases in
developed countries than in developing countries. This finding is not
unusual since rotavirus is considered to be the most common cause of
childhood diarrhoea in both developed and developing countries.112
Infections with enteric viruses have a strong relationship with seasons
and may be the reason for the higher incidence in OECD countries.
This relationship is particularly evident in OECD countries with a tem-
perate climate where rotavirus and norovirus infections often peak in
the cooler months.113,114 There is a less obvious seasonal distribution in
tropical countries.115 The burden of rotaviral diarrhoea worldwide has
resulted in the World Health Organization (WHO) placing priority on
the development and distribution of rotavirus vaccines globally.3 More
recently, a gradually decrease in the number of hospitalizations from
severe dehydrating diarrhoea in children has been observed since the
introduction of the rotavirus vaccine in the USA, in 2006,116 and in
Australia in 2007.117-119 Efficacy trials conducted in Africa,120 and a
post-marketing study conducted in Mexico, support the use of rotavirus
vaccines in the developing countries.121
Norovirus infection in developed settings was prevalent in adults
and nearly three times more common compared with children.
Norovirus is recognized as a leading cause of epidemic gastroenteritis
affecting all age groups, with sporadic cases occurring all year round
with increased incidence observed in colder months.113 In contrast to
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Table 4. Weighted average prevalence of enteric pathogens from adults >12 years in developing regions and OECD countries.
Regions MENA OECD SSA
No. of Studies (7) 1 4 2
Pathogens Detection rate % (95%CI) Detection rate % (95%CI) Detection rate % (95%CI)
Bacteria
Aeromonas sp. 0.7 (0.01-9.9) 0.2 (0.01-0.6) 0.3 (0.01-2.3)
Campylobacter jejuni 1.4 (0.2-9.1) 3.3 (0.9-12.0) 0.3 (0.01-2.3)
EPEC N/R 0.1 (0.01-0.5) 0.3 (0.01-2.3)
ETEC N/R 0.1 (0.01-0.5) 1.0 (0.3-2.7)
Other diarrh E. coli pathotypes 37 (26.7-48.6) 0.1 (0.01-0.5) 3.6 (0.3-36.2)
Salmonella spp. 0.7 (0.01-9.9) 1.9 (0.4-7.7) 4.0 (0.2-43.5)
Shigella spp. 4.1 (1.3-12.0) 0.2 (0.01-1.0) 2.2 (1.1-4.5)
Vibrio cholerae 0.7 (0.01-9.9) 0.1 (0.01-0.5) N/R
Viruses
Astrovirus 0.7 (0.01-9.9) 0.4 (0.01-2.9) 0.3 (0.01-2.3)
Adenovirus type 40/41 6.8 (2.9-15.4) 1.0 (0.4-2.4) 0.3 (0.01-2.3)
Norovirus 0.7 (0.01-9.9) 10.5 (7.5-14.7) 0.3 (0.01-2.3)
Rotavirus 1.4 (0.2-9.1) 3.6 (1.4-9.2) 0.3 (0.01-2.3)
Parasites
Ascaris 0.7 (0.01-9.9) 0.1 (0.01-0.5) 0.3 (0.01-2.3)
Blastocystis spp. 0.7 (0.01-9.9) 0.2 (0.01-1.5) 4.0 (0.5-24.7)
Cryptosporidium sp 0.7 (0.01-9.9) 0.3 (0.01-3.1) 9.4 (1.0-50.2)
Dientamoeba fragilis 0.7 (0.01-9.9) 0.1 (0.01-0.5) 0.3 (0.01-2.3)
Entamoeba spp. 1.4 (0.2-9.1) 0.2 (0.01-0.6) 2.5 (1.2-5.1)
Giardia intestinalis 0.7 (0.01-9.9) 0.3 (0.01-2.3) 1.4 (0.6-3.2)
EAP=East Asia & the Pacific; MENA = Middle East and North Africa; SAP= South Asia; LAC= Latin America and the Caribbean; SSA= Sub-Saharan Africa; OECD= Developed Countries including non-OECD developed
countries. EPEC- Enteropathogenic E. coli; ETEC- Enterotoxigenic E. coli.  
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rotavirus, norovirus is the principal cause of healthcare associated
viral diarrhoea.122 Enteric adenoviruses types 40 and 41 and astrovirus
are less frequently implicated but are also important causes of acute
diarrhoeal illnesses in sporadic and outbreak settings.114,122
Campylobacter spp, E. coli pathotypes and Shigella spp are frequent-
ly detected in children from developing regions while adults are pre-
dominantly affected by Cryptosporidium spp, Salmonella and pathogen-
ic E. coli. Bacterial diarrhoea can be spread through various routes
including contaminated food, water and the faecal-oral route; providing
multiple sources of infections among the exposed.6,28 The relatively
high prevalence of different strains of pathogenic E. coli found in both
adults and children in developing settings has been previously
described.10 One recent estimate of multiple diarrhoea pathogens in
older children and adults in outpatient and inpatient settings, found
ETEC and Vibrio cholera as the leading causes of hospitalization and
Salmonella sp, Shigella sp, and E. hystolitica as the leading causes in
out-patients.123 The prevalence of pathogenic E. coli in developed coun-
tries is usually sporadic and more closely associated with travel to a
developing regions.29,30,112Campylobacter spp and Salmonella spp were
the most common bacteria isolated in patients from OECD countries.
Evidence from the USA, New Zealand and Australia suggest that
Salmonella infections are a major cause of hospitalizations and deaths
annually, and are frequently associated with foodborne illnesses in
industrialized countries.124-126
Enteric protozoa, mainly Giardia intestinalis and Entamoeba spp
were common in children from developing regions compared with chil-
dren from developed settings. A recent meta-analysis found that
Giardia intestinalis was not associated with acute paediatric diarrhoea
but was associated with persistent diarrhoea in developing countries.
Adults, predominantly those in the SSA region, were mainly affected by
Cryptosporidium spp and Blastocystis spp., which has been previously
described in the SSA region.22 The prevalence of parasitic infections is
consistent with findings from other developing settings, where sanita-
tion and access to clean water is compromised.127-129 There are conflict-
ing interpretations about the role of Blastocystis spp as a pathogen, and
as a result some laboratories may not place priority on looking for or
reporting the presence of this parasite.130-132 However, several reports
have established its association with abdominal pain, persistent diar-
rhoea and irritable bowel syndrome,133-135 and other reports hypothe-
size that pathogenicity may be sub-type dependent.136
Limitations 
In systematically reviewing the literature, it became apparent that
only some studies utilised high level study design and analytical tech-
niques that could identify a broad range of enteric pathogens.
Accordingly, we limited our analysis to include only those studies that
utilised a rigorous methodology and clearly defined the patient group
(diarrhea cases) and the enteric pathogens detected. This study found
a higher prevalence of enteric viruses in developed countries compared
with developing countries. This difference however, might be due to
the different methods used to identify viral pathogens in the different
geographical areas, since some diagnostic methods are more sensitive
than others. Similar findings however have been found by the recently
completed GEMS study that employed a standardised protocol for sever-
al countries in sub-Saharan Africa and Asia.103,137,138 Additionally,
OECD countries are likely to have better testing regimes than many
developing countries, and as such they are more likely to identify
pathogens from infected persons. As such, care should be taken in
making comparisons across developed and developing regions. Another
limitation of this study was the lack of data to analyse the correlation
between the prevalence of enteric pathogens and seasons in different
countries. However, previous studies have shown correlations between
the prevalence of some pathogens and specific seasons. For example,
studies have described distinct seasonal patterns of increased preva-
lence of viral enteric infections in cooler months.50,139-141 Despite
regional variations, consistent summer peak in the incidence of bacte-
rial diseases has been observed across transnational boundaries, for
campylobacteriosis, salmonellosis and verotoxin producing E. coli
(VTEC).142 This consistent summer peak in bacterial diseases has been
widely described for both developing and developed suggesting possible
direct effects of large-scale environmental influences on a shared expo-
sure routes.143-147 For example increased incidence of infection with
common foodborne bacteria (e.g. Campylobacter, Salmonella spp) has
been reported in warmer months.148,149 Understanding disease specific
seasonal patterns is important for improving existing disease surveil-
lance methods and developing appropriate prevention strategies.
Conclusions 
This systematic review of the literature has attempted to provide an
estimation of the types and prevalence of gastrointestinal pathogens
associated with diarrhoeal illness in both developing and developed
settings. To our knowledge this systematic review is the first to provide
an estimate of the region specific prevalence of enteric pathogens
associated with diarrhoeal illnesses in both developed and developing
countries. Similar studies to provide a comparison were not found as
this was the first study to employ a broad definition of diarrhoeal ill-
ness, for adults and children. The current study addresses the gap in
the literature by providing region specific estimates of pathogen preva-
lence for adults and children worldwide. It concludes that pathogens
are consistently detected in persons seeking medical attention for diar-
rhoeal illnesses in secondary or primary care settings. This review
highlights the need for the development of inexpensive sensitive and
specific diagnostic methods to improve pathogen detection in clinical
laboratories. Global support is necessary for equitable access to
rotavirus vaccines in developing settings and for continued research
and development of cost effective interventions to prevent and control
diarrhoeal illnesses worldwide.
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